<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04983836</url>
  </required_header>
  <id_info>
    <org_study_id>19-AOI-04</org_study_id>
    <nct_id>NCT04983836</nct_id>
  </id_info>
  <brief_title>Comparison of Analgesic Efficiency Between Serratus Block and Paravertebral Block in Video-assisted Thoracic Surgery. Double-blind Randomized Comparative Non-inferiority Study (BSBP)</brief_title>
  <acronym>BSBP</acronym>
  <official_title>Comparison of Analgesic Efficiency Between Serratus Block and Paravertebral Block in Video-assisted Thoracic Surgery. Double-blind Randomized Comparative Non-inferiority Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, the 2 main techniques of regional loco anesthesia in perioperative analgesic&#xD;
      management of the thoracotomy remains the establishment of a thoracic epidural or&#xD;
      paravertebral block. On the other hand, there is no standard of perioperative analgesic&#xD;
      management in the case of thoracic surgery under video-thoracoscopy. The video-thoracoscopy,&#xD;
      by its mini-invasive character, makes the levels of pain lower in post-operative questioning&#xD;
      the benefit/risk balance of the paravertebral block. In 2013, Blanco published a new&#xD;
      technique of locoregional anesthesia called the block Serratus allowing analgesia of a&#xD;
      homolateral thorax hemi The latter by its simplicity of realization and its lesser risk is&#xD;
      growing in thoracic surgery. This pilot study finds an equivalence in total oxycodone&#xD;
      consumption in the first 2 post-operative days with a number of complications related to the&#xD;
      serratus block lower than the serratus block compared to the paravertebral block in&#xD;
      preoperative surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, comparative, monocentric, randomized non-inferiority interventional study, in double-blind.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain evaluation</measure>
    <time_frame>48 hours after the surgery</time_frame>
    <description>Assess the non-inferiority of the single-injection echo-guided serratus block, performed in video-thoracic surgery preoperative, on the post-operative mean pain during the first 48 hours, compared to the single-injection echo-guided paravertebral block with a simple numeric scale (from 0 to 10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Walking test</measure>
    <time_frame>24 hours after the surgery</time_frame>
    <description>Improvement of walking distance during the test at 6 min post-operative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative morphine dose Post operative administrated morphin dose</measure>
    <time_frame>48 hours after the surgery</time_frame>
    <description>Mesure of intraoperative morphine administrated dose and total morphine administrated dose (in mg).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine side effect quantification</measure>
    <time_frame>48 hours after the surgery</time_frame>
    <description>Collection of adverse reactions due to morphine administration (nausea, vomiting, pruritus, urine retention, respiratory depression)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalisation duration</measure>
    <time_frame>1 year</time_frame>
    <description>Number of hospitalisation days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Serratus Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Paravertebral Block</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Serratus anesthesia technique</intervention_name>
    <description>locoregional anaesthesia allowing analgesia of the hemi-thorax by ultrasound guided single injection of naropeine 5mg/ml</description>
    <arm_group_label>Serratus Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Paravertebral anesthesia technique</intervention_name>
    <description>Ultrasound guided single injection of of naropeine 5mg/ml dose into the paravertebral space next to the thoracic spine</description>
    <arm_group_label>Paravertebral Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Patient who has given their free, informed and signed consent&#xD;
&#xD;
          -  Social security affiliation;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant woman&#xD;
&#xD;
          -  guardianship / curatorship / private patient under public law&#xD;
&#xD;
          -  surgery to be performed urgently (less than 24 hours)&#xD;
&#xD;
          -  surgery redux&#xD;
&#xD;
          -  thoracotomy surgery&#xD;
&#xD;
          -  sternotomy surgery&#xD;
&#xD;
          -  pleurectomy&#xD;
&#xD;
          -  patient participating simultaneously in another research that may interfere with&#xD;
             results of the study&#xD;
&#xD;
          -  severe abnormality of haemostasis (80,000/ml platelets) and/or coagulation (TP 50%,&#xD;
             factor V 50%).&#xD;
&#xD;
          -  Prior use of morphine;&#xD;
&#xD;
          -  chronic pain/chest neuropathies&#xD;
&#xD;
          -  sepsis&#xD;
&#xD;
          -  patients with insulin-dependent diabetes and/or diabetic neuropathy.&#xD;
&#xD;
          -  severe kidney or liver failure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julie GARCIA, MD</last_name>
    <phone>+334 92 03 88 88</phone>
    <email>garcia.j2@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>CÃ©cile DUPUIS</last_name>
    <phone>+334 92 03 88 88</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de NICE</name>
      <address>
        <city>Nice</city>
        <state>Toutes</state>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Julie GARCIA, MD</last_name>
      <phone>+334 92 03 88 88</phone>
      <email>garcia.j2@chu-nice.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 19, 2021</study_first_submitted>
  <study_first_submitted_qc>July 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No data sharing in planned</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

